Aug 25, 2025 18:41
CLYM - Climb Bio, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.88 0.03 (1.6%) | --- | --- | -0.03 (-1.55%) | 0.07 (3.62%) | 0.03 (1.58%) | 0.0 (0.0%) | 0.0 (0.0%) |
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.13
- Diluted EPS:
- -0.13
- Basic P/E:
- -14.6923
- Diluted P/E:
- -14.6923
- RSI(14) 1m:
- 0.0
- VWAP:
- 1.91
- RVol:
- 0.9691
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 1.95 +0.03 (+1.56%) | Oct 15 14:16 |
| 1m | Price increase 1m | 1.91 +0.03 (+1.6%) | Oct 15 14:09 |
| 1m | Price decrease 1m | 1.81 -0.02 (-1.09%) | Oct 15 13:16 |
| 1m | Price increase 1m | 1.87 +0.02 (+1.08%) | Oct 15 11:52 |
| 1m | Price decrease 1m | 1.84 -0.02 (-1.31%) | Oct 15 11:11 |
Related News
May 19, 2025 20:34
Oct 11, 2024 16:30
Oct 04, 2024 11:00